BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27389080)

  • 1. Cerebral microbleeds in early Alzheimer's disease.
    Poliakova T; Levin O; Arablinskiy A; Vasenina E; Zerr I
    J Neurol; 2016 Oct; 263(10):1961-8. PubMed ID: 27389080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer's disease?
    Rabelo AG; Teixeira CV; Magalhães TN; Carletti-Cassani AFM; Amato Filho AC; Joaquim HP; Talib LL; Forlenza O; Ribeiro PA; Secolin R; Lopes-Cendes I; Cendes F; Balthazar ML
    Neuroradiol J; 2017 Oct; 30(5):477-485. PubMed ID: 28714354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
    Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Harada N; Nishida H; Nakajima H; Inuzuka T
    J Neurol; 2017 Feb; 264(2):373-381. PubMed ID: 28000005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cerebral microbleeds by susceptibility-weighted imaging in Alzheimer's disease patients: A neuroimaging biomarker of the disease.
    Sparacia G; Agnello F; La Tona G; Iaia A; Midiri F; Sparacia B
    Neuroradiol J; 2017 Aug; 30(4):330-335. PubMed ID: 28463092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
    Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
    J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment.
    Shams S; Granberg T; Martola J; Li X; Shams M; Fereshtehnejad SM; Cavallin L; Aspelin P; Kristoffersen-Wiberg M; Wahlund LO
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):621-8. PubMed ID: 26661151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias.
    Mendes A; Bertrand A; Lamari F; Colliot O; Routier A; Godefroy O; Etcharry-Bouyx F; Moreaud O; Pasquier F; Couratier P; Bennys K; Vercelletto M; Martinaud O; Laurent B; Pariente J; Puel M; Epelbaum S; Belliard S; Kaaouana T; Fillon L; Chupin M; Dubois B; Teichmann M;
    Neurology; 2018 Mar; 90(12):e1057-e1065. PubMed ID: 29444966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Metals and the Association with Cerebral Small Vessel Disease.
    Shams M; Martola J; Charidimou A; Granberg T; Ferreira D; Westman E; Wintermark M; Iv M; Larvie M; Kristoffersen Wiberg M; Kaijser M; Forsgard N; Zetterberg H; Wahlund LO; Shams S
    J Alzheimers Dis; 2020; 78(3):1229-1236. PubMed ID: 33104030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident Cerebral Microbleeds Detected by Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease.
    Basselerie H; Bracoud L; Zeestraten E; Bouguen E; Kiyasova V; Pueyo M; Cognard C; Dumas H; Gramada R; Ousset PJ; Vellas B; Bonneville F
    J Alzheimers Dis; 2017; 60(1):253-262. PubMed ID: 28826188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.
    Renard D; Tatu L; Collombier L; Wacongne A; Ayrignac X; Charif M; Boukriche Y; Chiper L; Fourcade G; Azakri S; Gaillard N; Mercier E; Lehmann S; Thouvenot E
    J Alzheimers Dis; 2018; 64(4):1113-1121. PubMed ID: 30010128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbleeds do not affect rate of cognitive decline in Alzheimer disease.
    van der Vlies AE; Goos JD; Barkhof F; Scheltens P; van der Flier WM
    Neurology; 2012 Aug; 79(8):763-9. PubMed ID: 22875093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral microbleeds are associated with cognitive decline early after ischemic stroke.
    Christ N; Mocke V; Fluri F
    J Neurol; 2019 May; 266(5):1091-1094. PubMed ID: 30761422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort.
    Shams S; Martola J; Charidimou A; Larvie M; Granberg T; Shams M; Kristoffersen-Wiberg M; Wahlund LO
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution.
    Chiang GC; Cruz Hernandez JC; Kantarci K; Jack CR; Weiner MW;
    AJNR Am J Neuroradiol; 2015 Sep; 36(9):1635-41. PubMed ID: 26228889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
    Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
    JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cerebral microbleeds in cerebrovascular and neurodegenerative diseases with cognitive impairment].
    Polyakova TA; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):19-27. PubMed ID: 27723706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.